Evidence map›Paper›PMID 22184325›Full record

ArticleHypertension (Dallas, Tex. : 1979)2012

Cytochrome P450 1B1 contributes to renal dysfunction and damage caused by angiotensin II in mice.

Brett L Jennings, Larry J Anderson, Anne M Estes, Fariborz A Yaghini, Xiao R Fang, Jason Porter, Frank J Gonzalez, William B Campbell, Kafait U Malik

Open access · bronzeAbstract read
In one paragraph

Article in Hypertension (Dallas, Tex. : 1979), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. CYP1B1 as a therapeutic target in cardio-oncology.Clinical science (London, England : 1979) · 2020
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Oxidative stress in hypertension: role of the kidney.Antioxidants & redox signaling · 2014
    Review
  20. Cyp1B1 expression promotes angiogenesis by suppressing NF-κB activity.American journal of physiology. Cell physiology · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Brett L JenningsDepartment of Pharmacology, College of Medicine, 874 Union Ave, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
Larry J Anderson
Anne M Estes
Fariborz A Yaghini
Xiao R Fang
Jason Porter
Frank J Gonzalez
William B Campbell
Kafait U Malik
National Cancer Institute · US

Funding

Angiotensins, Prostaglandins and Adrenergic InteractionsR01HL019134 · NHLBI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI KAFAIT U MALIK · 1985 to 2026
$14.7M
Endothelial Lipoxygenase Metabolites and Vascular ToneR01HL103673 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI CAMPBELL, WILLIAM BRYSON · 2011 to 2014
$1.5M
NHLBI NIH HHS R01 HL019134NHLBI NIH HHS R01 HL103673NHLBI NIH HHS R01-HL-103673NHLBI NIH HHS R01-HL-19134-36
6 · The paper itself

Abstract

Cytochrome P450 1B1 contributes to the development of angiotensin II-induced hypertension and associated cardiovascular pathophysiology. In view of the critical role of angiotensin II in the kidney, as well as in salt and water homeostasis, and blood pressure regulation, we determined the contribution of cytochrome P450 1B1 to renal dysfunction and injury associated with angiotensin II-induced hypertension in male Cyp1b1(+/+) and Cyp1b1(-/-) mice. Angiotensin II infusion (700 ng/kg per minute) given by miniosmotic pumps for 13 and 28 days increased systolic blood pressure in Cyp1b1(+/+) mice; this increase was significantly reduced in Cyp1b1(-/-) mice. Angiotensin II increased renal Cyp1b1 activity, vascular resistance, and reactivity to vasoconstrictor agents and caused endothelial dysfunction in Cyp1b1(+/+) but not Cyp1b1(-/-) mice. Angiotensin II increased water consumption and urine output, decreased urine osmolality, increased urinary Na(+) and K(+) excretion, and caused proteinuria and albuminuria in Cyp1b1(+/+) mice that was diminished in Cyp1b1(-/-) mice. Infusion of angiotensin II for 28 but not 13 days caused renal fibrosis, tubular damage, and inflammation in Cyp1b1(+/+) mice, which was minimized in Cyp1b1(-/-) mice. Angiotensin II increased levels of 12- and 20-hydroxyeicosatetraenoic acids; reactive oxygen species; and activity of NADPH oxidase, extracellular signal-regulated kinase 1/2, p38 mitogen-activated protein kinase, and c-Src in the kidneys of Cyp1b1(+/+) but not Cyp1b1(-/-) mice. These data suggest that increased thirst, renal dysfunction, and injury and inflammation associated with angiotensin II-induced hypertension in mice depend on cytochrome P450 1B1 activity, thus indicating that cytochrome P450 1B1 could serve as a novel target for treating renal disease and hypertension.

Indexed as

Angiotensin IIAnimalsAryl Hydrocarbon HydroxylasesBlood PressureCSK Tyrosine-Protein KinaseCytochrome P-450 CYP1B1Disease Models, AnimalEndothelium, VascularExtracellular Signal-Regulated MAP KinasesFibrosisHypertensionKidneyMaleMiceMice, KnockoutNADPH OxidasesAngiotensin IIAryl Hydrocarbon HydroxylasesCSK Tyrosine-Protein KinaseCyp1b1 protein, mouseCytochrome P-450 CYP1B1Extracellular Signal-Regulated MAP KinasesNADPH OxidasesProtein-Tyrosine KinasesReactive Oxygen SpeciesSodiumsrc-Family Kinases

Identifiers

PMID22184325
PMCPMC3268066
OpenAlexW2136483252

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.